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SUMMARY 
Background:  The root bark extract of Zanthoxylum 
xanthozyloides is used in folklore medicine in Ghana 
and Nigeria to treat inflammation.  A previous pharma-
cological study confirmed the anti-inflammatory activ-
ity of the extract.   
Objective: To study the effect of the extract on vascu-
lar response in inflammation. 
Method: The extract was obtained by Soxhlet extrac-
tion and rotatory evaporation, followed by freeze-
drying. Groups of rats (with carrageenin-induced paw 
inflammation) and mice (with xylene-induced pinna 
inflammation) were, respectively, assigned randomly to 
treatment groups. The animals were given three differ-
ent treatments orally:  0.9% saline (control), the extract 
(400mg/kg and 800mg/kg for mice; 1000mg/kg, 2000 
mg/kg, and 4000mg/kg for rats), and indomethacin 
(5mg/kg and 10mg/kg for mice; 10mg/kg, 20mg/kg, 
and 40mg/kg for rats). In another set of experiment, 
each treatment group received phenylephrine subcuta-
neously (30µg/kg for rats and 20µg/kg for mice) in 
addition to the specified treatment aforementioned. In 
both sets of experiments, each group of rats was rotated 
through the entire treatment groups such that each ani-
mal served as control as well as received all the treat-
ments. Analysis of variance was used as the statistical 
test.  
Results: The extract and indomethacin both caused 
dose-dependent reduction in the carrageenin-induced 
increase in paw volume in rats and also reduced xy-
lene-induced increase in blood flow in mice pinna ar-
teries. Phenylephrine enhanced the decrease in capil-
lary permeability and vasodilatation caused by low 
dose extract but not that caused by high dose extract or 
both low and high dose indomethacin. 
Conclusion: The extract reduced vasodilatation and 
decreased capillary permeability in inflammation. 
 
Keywords: Root bark extract, Zanthoxylum xanthoxy-
loides, capillary permeability, vasodilatation, inflam-
mation. 
INTRODUCTION 
Zanthoxylum xanthoxyloides (a member of the family 
Rutaceae) is a stout tree that grows wild in coastal 
grassland, closed forest, and in the Guinea savannah.  
The root bark extract is used in folklore medicine in 
Ghana and Nigeria to treat various conditions, notably, 
inflammation.1 
 
The initial step of the inflammatory process is vascular 
response which comprises vasodilatation and increased 
capillary and venular permeability as well as endothe-
lial expression of cell adhesion molecules.  The vascu-
lar response culminates in excess accumulation of fluid 
in the tissue (oedema) while the vasodilatation is ex-
pressed outwardly as an area of reddening (erythema). 
 
Previous study of anti-inflammatory activity of isolated 
and purified alkaloids of the root bark of Z. xanthoxy-
loides employed plethysmometry to measure volume 
changes in carrageenin-induced inflammation in rat 
paw, using decrease in paw volume as an index of the 
anti-inflammatory activity.2 Decrease in paw volume 
could be due to either decreased blood flow into the 
capillaries consequent to vasoconstriction or decreased 
capillary permeability or to both mechanisms. The 
plethysmometry method alone, however, cannot dis-
criminate such mechanisms. 
 
A rational approach to assessing the anti-inflammatory 
activity of the extract at the vascular level, therefore, 
entails studying the effect of the extract on oedema and 
erythema, using experimental animal models that test 
for oedema and erythema.  Accordingly, the mouse 
pinna inflammation (for erythema) 3 and carrageenin-
induced inflammation in rat paw (for oedema) 4 were 
used as test models to elicit the effect of the root bark 
extract on vascular response in inflammation. All the 
doses of the extract used were within the dose range 
(on the dose axis) corresponding to the linear portion of 
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MATERIALS AND METHODS 
Collection and extraction of the root bark 
The roots of Z. xanthoxyloides (identified and con-
firmed in the Department of Botany, University of 
Ghana, Legon) were collected from a forest at Akatsi, 
Volta Region, in the month of August and solar-dried 
for 1 day. The root barks were removed, washed, and 
dried in hot oven (55OC) for five days. The dried root 
barks were pulverized to powder. Aliquot of the pow-
der, 300g, was extracted in water, 3L, in Soxhlet appa-
ratus5. The extraction was allowed to continue until a 
point  where no more brown colouration was im-
parted to the water. This was used as an index for com-
pletion of extraction. The clear brown extract was con-
centrated 10-fold in a rotatory evaporator (RE-100 
(Bibby Sterilin, Newport, U.K.). The viscous brown 
fluid was freeze-dried in Edward Modulyo freeze-dryer 
(Edwards High Vacuum, Crawley, U.K.). The freeze-
dried powder was stored at –18oC until when needed. 
Reconstituted freeze-dried powder in 0.9% saline is 
referred to as “the extract” in this text.  
  
Carrageenin- induced inflammation 
Thirty-five Wistar rats (150-200g) of both sexes (18 
males and 17 females) were randomly assigned to 7 
treatment groups of 5 rats each. The volumes of the 
right hind paw of each rat (Vo) were measured by wa-
ter displacement in a plethysmometer (Ugo Basile, 
Comerio, Italy). The rats were then treated as follows: 
one group received 0.9% saline on  weight basis (con-
trol); three groups received three dose levels of indo-
methacin, 10mg/kg, 20mg/kg and 40mg/kg respec-
tively; and the remaining three groups received three 
dose levels of the extract, 1000mg/kg, 2000mg/kg and 
4000mg/kg respectively. The doses were given orally. 
One hour after treatment, 0.1 ml of 1% (w/v) carra-
geenin in 0.9% saline was injected into the subplantar 
surface of the right hind paw of each rat to induce in-
flammation. The paw volume of each rat (Vt) was 
measured again at 1, 2, 3, 4 and 5hr after the injection 
of the inflammatory agent. Each group of rats was ro-
tated through the entire seven treatment groups (ran-
domized complete block design), and paw volumes 
measured in each rotation. Thus each rat served as a 
control as well as received the other six treatments. The 
hind paws used for induction of inflammation were 
alternated during the rotations, and the animals were 
rested for one week after every two rotations at 3-day 
interval.  
 
Another set of 25 Wistar rats (150-200g) of both sexes 
(12 males and 13 females) was randomly assigned to 5 
treatment groups of 5 rats each.  Paw volume of each 
rat was measured. One group was given 0.9% saline on 
weight basis (control); two  groups received two dose 
levels of indomethacin, 10mg/kg and 40mg/kg respec-
tively; and the remaining two groups, two dose levels 
of the extract, 1000mg/kg and 4000mg/kg respectively.  
Each treatment group was also given phenylephrine, 
30µg/kg, subcutaneously. 
 
Mouse pinna inflammation 
Twenty-five Balb/C mice (25-35g) of both sexes (13 
males and 12 females) were randomly assigned to 5 
treatment groups of 5 mice each. One group received 
0.9% saline on weight basis (control); two groups were 
given two dose levels of indomethacin, 5mg/kg and 
10mg/kg, respectively; and the remaining two groups, 
two dose levels of the extract, 400mg/kg and 800mg/kg 
respectively. All doses were given orally. One hour 
after receiving treatment, each mouse was restrained in 
a narrow holder and 0.1 ml of Evan’s blue dye injected 
through the tail vein. The dye was allowed to equili-
brate in the circulation for 30min to 1hr. Under ether 
anaesthesia, a drop of xylene was inoculated into the 
right pinna by pricking it with a 26G hypodermic nee-
dle through the drop. Fifteen minutes later, the animals 
were euthanised and their ears severed. The diameter of 
the blue patch at the site of inoculation was measured 
with a pair of dividers and the area calculated.  
 
Another set of 25 Balb/C mice (25-35g) of both sexes 
(13 males and 12 females) was randomly assigned to 5 
treatment groups of five mice each.  One group re-
ceived 0.9% saline on weight basis (control); two 
groups, 400mg/kg and 800mg/kg of the extract respec-
tively; and the remaining two groups, 5mg/kg and 
10mg/kg of indomethacin respectively. Each treatment 




The average paw volume for each treated rat group in 
the Carrageenin- induced inflammation experiment was 
determined and compared with that obtained for each 
group before treatment. Percentage increase in paw 
volume (P %) was derived, using the formula: 
      P %={( Vt-Vo)/Vo} x 100  
Where Vt = the average paw volume at a given time, t, 
and Vo = the average paw volume at zero time. 
              
Percent reduction in paw volume (I %), at a given time, 
caused by a treatment was computed from the follow-
ing equation: 
                I% = {1- (Pt/Po)} x 100 
Where Pt = mean percentage increase in paw volume 
of drug or the extract treated rats at time, t.   
Po = mean percentage increase in paw volume of con-
trol rats at the specified time. 
 
The mean blue patch area of each treated group in the 
pinna inflammation experiment was calculated and 
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compared with that of the control group. The mean 
percent reduction in the area, I%, was calculated for 
each group, using the equation: 
         I %= {1- (A/Ao)} x 100 
Where A = mean area of blue patch in drug or extract 
treated group. Ao = mean area of blue patch in control 
group. 
 
Statistical analysis of the data was performed using 
analysis of variance to test the difference in the means 
of groups. The difference between the average mean 
paw volume (ml) of the treated rats and those of the 
control at the specified time intervals was expressed as 
percent reduction of the control. In the figures, each 
point represents the mean percentage reduction in paw 
volume of 35 rats. Differences at p<0.05 were consid-
ered statistically significant. 
 
RESULTS 
In animals given saline (control), 0.1 ml of 1% (w/v) 
carrageenin in 0.9% saline increased paw volume sig-
nificantly (p<0.05). Increased paw volume was notice-
able at 1hr, peaked at 3hr and thereafter reduced rela-
tively. Percentage increase in paw volume was 65% at 
1hr, 73% at 3hr and 68% at 5hr after injection of carra-
geenin. The extract (Figure 1) and indomethacin (Fig-
ure 2) significantly reduced the carrageenin-induced 
increase in paw volume. The percentage reduction dif-
fered significantly among groups of rats (p<0.05) given 
different dose levels of the extract and indomethacin. 
 
 
Figure 1 Percentage reduction of oedema in the right 
hind paw of rats by the extract (■–■, 1000mg/kg; ▲–
▲, 2000mg/kg; and ♦–♦, 4000mg/kg).  
 
 
Figure 2: Percentage reduction of oedema in the right 
hind paw of rats by indomethacin (♦–♦, 10mg/kg; ■–■, 
20 mg/kg; ▲–▲, 40 mg/kg).  
 
The extract caused significant (p<0.05) dose-dependent 
reduction in the carrageenin-induced increase in paw 
volume, with maximum percentage reduction observed 
4hr after injection of the inflammatory agent (Figure 
1). The maximum percentage reduction in paw volume 
caused by 1000, 2000, and 4000mg/kg extract was 
18%, 27% and 42% respectively. Indomethacin, like 
the extract, dose-dependently reduced the carrageenin-
induced increase in paw volume. The maximum per-
centage reduction in paw volume observed at 10mg/kg 
was 47% (Figure 2).  However, the percentage reduc-
tion did not reach a maximum at the higher dose levels. 
Compared to the extract, indomethacin caused a sig-
nificantly greater reduction in paw volume (p<0.05) at 
the three dose levels at all the specified time intervals 
except at 2hr after injecting the inflammatory agent 
when there was no significant difference (p=0.693) 
between 10 mg/kg indomethacin and 4000 mg/kg ex-
tract; each causing 19% reduction in paw volume. 
 
Phenylephrine enhanced significantly (p=0.047) the 
reduction in paw volume caused by low dose 
(1000mg/kg) of the extract (Table 1) from 20% to 39% 
but had no significant effect (p=0.918) on that caused 
by the large dose (4000mg/kg).  
 
Phenylephrine, also, did not have any significant effect 
(p>0.05) on the percentage reduction in paw volume 
caused by low (10mg/kg) or high (40mg/kg) dose of 
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Table 1 Effect of the extract and indomethacin on carrageenin-induced rat paw oedema (paw volume) in the pres-
ence (+) and absence (-) of phenylephrine.  
        
Treatment 
 
     Mean Volume (ml) ± SEM 
 















Control 2.72  ±  0.25     
Extract, 1000mg/kg 2.12  ±  0.32 1.67  ±  0.31 20.3 38.6 0.047 
Extract, 4000mg/kg 1.61  ±  0.21 1.54  ±  0.18 41.0 43.2 0.923 
Indomethacin, 10mg/kg 1.47  ±  0.17 1.43  ±  0.13 45.7 47.3 0.941 
Indomethacin, 40mg/kg 0.64  ±  0.09 0.74  ±  0.10 76.4 72.9 0.864 
 
 
Table 2:  Effect of the extract and indomethacin on pinna blood flow in xylene-induced mouse pinna inflammation 





Mean area (mm2) ± SEM 
 
















Control  76.02  ±  5.95     
Extract, 400 mg/kg 33.10  ±  5.24 10.46  ±  2.23 56.5 86.8 0.042 
Extract, 800 mg/kg 19.14  ±  2.20 6.69  ±  1.71 74.8 91.2 0.196 
Indomethacin, 5 mg/kg 11.80  ±  2.31 6.56  ±  3.51 84.5 91.4 0.582 
Indomethacin,10 mg/kg 6.90  ±  2.33 3.10  ±  1.83 90.9 96.0 0.560 
 
 
Although the percentage increase in paw volume/time 
profile was identical for the extract and indomethacin 
the slope of the curves was steeper for indomethacin 
than the extract. At 5hr after administration of carra-
geenin, indomethacin retained a significantly greater 
activity (p<0.05) than the extract. The profiles of the 
percentage reduction/time curves of indomethacin and 
the extract were different (Figures 1 and 2). The curves 
for the extract at all dose levels and 10mg/kg indo-
methacin consist of three portions: initial gentle slope, 
middle steep slope and a plateau whilst the curves for 
indomethacin at 20mg/kg and 40mg/kg, comprise two 
contiguous linear portions: one with a gentle slope and 
the other, a steep slope. Indomethacin retained a sig-
nificantly greater activity (p<0.05) than the extract 5hr 
after their administration.  
 
Xylene-induced inflammation in the pinna of mice was 
fully elicited in the saline treated group but was signifi-
cantly reduced (p < 0.05) by both indomethacin and the 
extract at all dose levels tested (Table 2).  The extract, 
like indomethacin, dose-dependently reduced (p<0.05) 
the area of blue patch observed in the pinna.  
 
Compared to the extract, indomethacin reduced the 
area of the blue patch more significantly (p<0.05): 400 
mg/kg and 800 mg/kg extract reduced the area by 57% 
and 75% respectively whilst indomethacin 5mg/kg and 
10mg/kg caused 85% and 91% reduction respectively.  
In the presence of phenylephrine, the extract, 
400mg/kg and 800mg/kg, reduced the blue patch area 
by 87% and 91% respectively (Table 2) whilst indo-
methacin, 5mg/kg and 10mg/kg, caused 91% and 96% 
reduction respectively. Thus phenylephrine enhanced 
the reduction in the blue patch area caused by 
400mg/kg extract more significantly (p<0.05) than that 
caused by both he low and high dose indomethacin. 
 
DISCUSSION 
The vascular response to the crude extract of Z. 
xanthoxyloides in inflammation was studied in two 
established laboratory models, namely, carrageenin-
induced rat paw oedema and xylene-induced mouse 
pinna inflammation. The data show that both the ex-
tract and indomethacin dose-dependently reduced car-
rageenin-induced increase in the paw volume of rats, 
and also reduced xylene-induced increase in pinna 
blood flow in mice. The decrease in blue patch area in 
the mouse pinna inflammation model indicates that the 
extract or indomethacin reduced blood flow consequent 
to reduction of vasodilatation.  
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This is supported by the observation that 
phenylephrine, a vasoconstrictor, significantly (p<0.05) 
enhanced the reduction of the blue patch area caused 
by the extract. Although phenylephrine also enhanced 
the reduction of the blue patch area caused by indo-
methacin, the percentage enhancement was not signifi-
cant at p<0.05.This is because indomethacin might 
have reduced vasodilatation completely and, therefore, 
phenylephrine could not constrict the vessels to a sig-
nificant extent. Consequently, blood flow and, hence, 
blue patch area was not significantly reduced by 
phenylephrine. 
 
The extract, likewise indomethacin, reduced oedema 
formation which could be due to either decreased capil-
lary permeability or reduced blood flow into capillaries 
as a result of reduced vasodilatation or to both mecha-
nisms. Phenylephrine was used to discriminate these 
possible mechanisms underlying the reduction of oe-
dema formation by the extract and indomethacin. In the 
presence of the extract or indomethacin, phenylephrine 
was expected to prevent the development of oedema if 
the reduction of oedema formation caused by the ex-
tract or indomethacin was solely due to reduced blood 
flow to the capillaries. In the present study, 
phenylephrine did not prevent oedema formation but 
enhanced the percentage reduction in oedema forma-
tion caused by low dose (1000mg/kg) of the extract. 
The percentage reduction in oedema formation caused 
by large dose extract (4000mg/kg), low dose indo-
methacin (10mg/kg) or large dose indomethacin 
(40mg/kg) was, however, not significantly changed by 
phenylephrine. The difference in the effect of 
phenylephrine in the presence of low dose extract, on 
one hand, and in the other regimens, on the other hand, 
could be due to the difference in the degree of vaso-
dilatation. Low dose extract did not reduce vasodilata-
tion completely and, therefore, phenylephrine was able 
to constrict the arteries to further reduce blood flow 
and, hence, enhanced the reduction in oedema forma-
tion. In the other regimens, reduction of vasodilatation 
was complete and, therefore, phenylephrine could not 
constrict the arterioles to enhance reduction in blood 
flow to the capillaries. The data suggest that the de-
crease in paw volume or oedema caused by the extract 
or indomethacin was not solely due to reduction in 
blood flow into the capillaries but, also, partly to de-
creased capillary permeability.  
 
The profile of the activity (reduction in oedema)/time 
curve would seem to suggest that oedema-reducing 
activity of the extract may involve more than one proc-
ess and may be related to the sequential release of 
chemical mediators.6 Thus the three portions of the   
curve may each represent interaction of the extract with 
different chemical mediators at different times. Alter-
natively, the lower and middle portions of the curve 
may each represent interaction with different chemical 
mediators whilst the upper portion of the curve repre-
sents wearing-off of the extract effect. Discrimination 
of these interactions would require time-dependent 
measurements of the various chemical mediators in the 
presence and absence of their respective blockers. This 
would provide an insight to the molecular mechanisms 




The study of vascular response to the extract of the root 
bark of Z. xanthoxyloides in inflammation, using carra-
geenin-induced paw oedema and xylene-induced 
mouse pinna inflammation has revealed that the extract 
as well as indomethacin decreased both capillary per-
meability and vasodilatation in inflammation. Since the 
extract shared similar vascular response property with 
indomethacin, a standard NSAID, it could be inferred 
that decrease in both capillary permeability and vaso-
dilatation may contribute to the anti-inflammatory ac-
tivity of the extract. Further study involving temporal 
measurements of biomarkers for inflammation would 
be required to identify the molecular mechanisms un-
derlying the vascular response to the extract in inflam-
mation.   
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